SPRB
SPRB
NASDAQ · Biotechnology

Spruce Biosciences Inc

$72.40
+1.55 (+2.19%)
As of Feb 8, 2:15 PM ET ·
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Buy 7 70%
Hold 3 30%
Sell 0 0%
Price Target
Analyst Price Target -38.1% upside
Low Target $31.89
Average Target $44.79
High Target $48.55
Current Price $72.40
Current
$72.40
Target
$44.79
$31.89 $44.79 avg $48.55
Scenario Analysis
Bear Case
$31.89
-56.0%
Low target
Base Case
$44.79
-38.1%
Avg target
Bull Case
$48.55
+-32.9%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$37.44
93.4% from high
52-Week Low
$21.27
+240.4% from low
Target vs 52W High
$44.79
+19.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%